Voya Financial Advisors Inc. Sells 164 Shares of Colgate-Palmolive (NYSE:CL)


Share on StockTwits

Voya Financial Advisors Inc. lessened its holdings in shares of Colgate-Palmolive (NYSE:CL) by 1.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,392 shares of the company’s stock after selling 164 shares during the quarter. Voya Financial Advisors Inc.’s holdings in Colgate-Palmolive were worth $711,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also made changes to their positions in CL. Wolff Wiese Magana LLC bought a new position in Colgate-Palmolive in the fourth quarter worth $25,000. Advisory Alpha LLC bought a new position in Colgate-Palmolive in the third quarter worth $28,000. Grant Street Asset Management Inc. bought a new position in Colgate-Palmolive in the fourth quarter worth $28,000. Accel Wealth Management bought a new position in Colgate-Palmolive in the fourth quarter worth $33,000. Finally, Kinloch Capital LLC bought a new position in Colgate-Palmolive in the fourth quarter worth $34,000. Institutional investors own 76.47% of the company’s stock.

Colgate-Palmolive stock opened at $79.62 on Thursday. The company has a debt-to-equity ratio of 6.50, a current ratio of 0.97 and a quick ratio of 0.62. Colgate-Palmolive has a one year low of $65.54 and a one year high of $86.41. The stock has a market capitalization of $67.48 billion, a PE ratio of 25.44, a price-to-earnings-growth ratio of 3.83 and a beta of 0.59. The business’s fifty day moving average is $76.89 and its 200 day moving average is $80.38.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Thursday, January 28th. The company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.76 by $0.01. Colgate-Palmolive had a return on equity of 383.88% and a net margin of 16.65%. The company had revenue of $4.32 billion for the quarter, compared to analysts’ expectations of $4.15 billion. During the same period last year, the firm posted $0.73 earnings per share. Colgate-Palmolive’s revenue was up 7.7% compared to the same quarter last year. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.05 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, May 14th. Shareholders of record on Wednesday, April 21st will be given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.26%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Tuesday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 62.19%.

In other Colgate-Palmolive news, insider Jennifer Daniels sold 20,692 shares of the firm’s stock in a transaction dated Thursday, February 4th. The stock was sold at an average price of $78.65, for a total value of $1,627,425.80. Following the transaction, the insider now directly owns 55,585 shares of the company’s stock, valued at $4,371,760.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider John W. Kooyman sold 463 shares of the firm’s stock in a transaction dated Tuesday, February 16th. The stock was sold at an average price of $77.16, for a total value of $35,725.08. Following the completion of the transaction, the insider now directly owns 7,160 shares in the company, valued at approximately $552,465.60. The disclosure for this sale can be found here. Insiders sold 30,810 shares of company stock worth $2,418,650 over the last three months. Insiders own 0.78% of the company’s stock.

A number of equities research analysts have recently commented on CL shares. Royal Bank of Canada cut Colgate-Palmolive from an “outperform” rating to a “sector perform” rating and set a $90.00 target price on the stock. in a research note on Monday, January 4th. Berenberg Bank raised Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $76.00 target price on the stock in a research note on Tuesday, January 26th. Credit Suisse Group raised Colgate-Palmolive from an “underperform” rating to a “neutral” rating and increased their target price for the stock from $70.00 to $80.00 in a research note on Monday, February 1st. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $83.00 target price on the stock. in a research note on Thursday, January 28th. Finally, Sanford C. Bernstein started coverage on Colgate-Palmolive in a research note on Tuesday, January 19th. They issued an “underperform” rating and a $77.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $81.91.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.

Featured Article: What is a resistance level?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.